Printer Friendly

Yissum obtains United States patent.

Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, Israel) has patented a method of producing a recombinant polypeptide having .beta.-glucosidase enzymatic activity, a polynucleotide encoding the polypeptide, nucleic acid constructs carrying the polynucleotide, transformed cells, such as yeast cells, and transgenic organisms expressing the polynucleotide. The invention provides various uses of the polypeptide, the polynucleotide, cells and/or organisms, including producing a recombinant polypeptide having .beta.-glucosidase enzymatic activity, increasing the level of aromatic compounds in alcoholic beverages, as well as other fermentation products of plant material, hydrolyzing cellobiose and thus increasing the level of fermentable glucose, increasing the production of alcohol; such as ethanol from plant material, increasing the aroma released from a plant, or a plant, product, and hydrolysis or transglycosylation of glycosides. (US 7,223,902)
COPYRIGHT 2007 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Yissum Research Development Company
Publication:BIOTECH Patent News
Article Type:Brief article
Date:May 1, 2007
Words:133
Previous Article:Mendel obtains United States patent.
Next Article:Research Development Foundation obtains United States patent.
Topics:


Related Articles
Yissum obtains United States patent.
Research Development Foundation obtains United States patent.
YISSUM TO COMMERCIALIZE BIODEGRADABLE PLASTIC.
Amarin signs agreement to acquire Ester Neurosciences.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters